Related Experiment Video
Updated: Jul 16, 2026
07:08
Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Endocrine Disruptors and Gynecological Malignancies
Dimitris Baroutis1, Eleni Katsianou2, Konstantinos Koukoumpanis1
11st Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Diagnostics (Basel, Switzerland)
|July 15, 2026
Summary
Endocrine-disrupting chemicals (EDCs) are linked to gynecological cancers like breast and endometrial cancer. Reducing EDC exposure, especially during development, is crucial for prevention and early detection strategies.
Area of Science:
- Environmental Health
- Gynecologic Oncology
- Toxicology
Background:
- Endocrine-disrupting chemicals (EDCs) disrupt hormonal balance, contributing to gynecological malignancies.
- Evidence links EDC exposure to breast, endometrial, ovarian, and cervical cancers.
Purpose of the Study:
- Synthesize current evidence on EDC exposure and gynecological cancers.
- Examine molecular mechanisms, epidemiology, and clinical implications.
- Assess diagnostic and prevention strategies.
Main Methods:
- Comprehensive literature review across major databases (PubMed, Embase, Scopus, Cochrane).
- Inclusion of systematic reviews, meta-analyses, cohort, and case-control studies.
- Quality appraisal using Newcastle-Ottawa Scale, AMSTAR-2, and GRADE framework.
Main Results:
- Major EDCs (bisphenols, phthalates, PCBs, pesticides, PFAS) show carcinogenic potential via hormonal and epigenetic pathways.
- Strongest evidence links DDT/DDE to increased breast cancer risk (up to 3.7-fold).
- Endometrial cancer associated with xenoestrogen mixtures; ovarian and cervical cancers show emerging links.
Conclusions:
- EDCs contribute to gynecological cancers through convergent molecular pathways.
- Causal inference is limited by observational data and exposure complexity.
- Integrate EDC risk into models, use multi-omics biomarkers, and prioritize exposure reduction.
Related Concept Videos
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:27Major Hormones and Their Functions
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
01:29The Endocrine System
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:22Target Cell Response to Hormones
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...